Administration of AD-MSCs cultured under low-serum condition promoted expansion of immunoregulatory CD163+ macrophages, a phenotype associated with IL10 production, more efficiently than AD-MSCs under normal serum conditions in a rat model of anti-GBM GN, protecting from crescent formation [128]. Here, CD163 is linked to Alzheimer disease.